nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicardipine—ABCB1—colon cancer	0.353	1	CbGaD
Nicardipine—CYP2B6—Irinotecan—colon cancer	0.0462	0.157	CbGbCtD
Nicardipine—CYP2C9—Capecitabine—colon cancer	0.0395	0.134	CbGbCtD
Nicardipine—CYP3A5—Irinotecan—colon cancer	0.0364	0.124	CbGbCtD
Nicardipine—CYP2C8—Fluorouracil—colon cancer	0.0336	0.114	CbGbCtD
Nicardipine—CYP3A5—Vincristine—colon cancer	0.0318	0.108	CbGbCtD
Nicardipine—ABCB1—Irinotecan—colon cancer	0.0237	0.0805	CbGbCtD
Nicardipine—CYP2C9—Fluorouracil—colon cancer	0.0234	0.0796	CbGbCtD
Nicardipine—ABCB1—Vincristine—colon cancer	0.0207	0.0703	CbGbCtD
Nicardipine—CYP3A4—Irinotecan—colon cancer	0.0142	0.0482	CbGbCtD
Nicardipine—ABCB1—Methotrexate—colon cancer	0.0125	0.0426	CbGbCtD
Nicardipine—CYP3A4—Vincristine—colon cancer	0.0124	0.0421	CbGbCtD
Nicardipine—CHRM3—ureter—colon cancer	0.0121	0.115	CbGeAlD
Nicardipine—CHRM3—muscle of abdomen—colon cancer	0.00871	0.0831	CbGeAlD
Nicardipine—Pericarditis—Fluorouracil—colon cancer	0.00293	0.0264	CcSEcCtD
Nicardipine—Peripheral vascular disorder—Irinotecan—colon cancer	0.0027	0.0243	CcSEcCtD
Nicardipine—PDE1A—smooth muscle tissue—colon cancer	0.0025	0.0238	CbGeAlD
Nicardipine—PDE1A—renal system—colon cancer	0.00241	0.0229	CbGeAlD
Nicardipine—CALM2—endothelium—colon cancer	0.00226	0.0216	CbGeAlD
Nicardipine—CALM1—endothelium—colon cancer	0.00225	0.0215	CbGeAlD
Nicardipine—CALM2—blood vessel—colon cancer	0.00208	0.0199	CbGeAlD
Nicardipine—CALM1—blood vessel—colon cancer	0.00208	0.0198	CbGeAlD
Nicardipine—CALM2—gall bladder—colon cancer	0.00196	0.0187	CbGeAlD
Nicardipine—CHRM5—epithelium—colon cancer	0.00185	0.0177	CbGeAlD
Nicardipine—ADRA1D—epithelium—colon cancer	0.00166	0.0158	CbGeAlD
Nicardipine—ADRA1B—renal system—colon cancer	0.00157	0.015	CbGeAlD
Nicardipine—Pericarditis—Methotrexate—colon cancer	0.00153	0.0137	CcSEcCtD
Nicardipine—Vasodilation—Irinotecan—colon cancer	0.00151	0.0136	CcSEcCtD
Nicardipine—Vasodilation procedure—Irinotecan—colon cancer	0.00151	0.0136	CcSEcCtD
Nicardipine—CACNA1C—smooth muscle tissue—colon cancer	0.00149	0.0142	CbGeAlD
Nicardipine—PDE1A—liver—colon cancer	0.00147	0.014	CbGeAlD
Nicardipine—Deep vein thrombosis—Capecitabine—colon cancer	0.00146	0.0131	CcSEcCtD
Nicardipine—CACNB2—digestive system—colon cancer	0.00145	0.0139	CbGeAlD
Nicardipine—Supraventricular tachycardia—Capecitabine—colon cancer	0.00135	0.0122	CcSEcCtD
Nicardipine—PDE1B—lymph node—colon cancer	0.00134	0.0128	CbGeAlD
Nicardipine—CACNB2—vagina—colon cancer	0.00128	0.0123	CbGeAlD
Nicardipine—CACNA2D1—bone marrow—colon cancer	0.00126	0.012	CbGeAlD
Nicardipine—CALM3—smooth muscle tissue—colon cancer	0.00125	0.0119	CbGeAlD
Nicardipine—CALM2—embryo—colon cancer	0.00124	0.0119	CbGeAlD
Nicardipine—CALM1—embryo—colon cancer	0.00124	0.0118	CbGeAlD
Nicardipine—Throat sore—Capecitabine—colon cancer	0.00123	0.0111	CcSEcCtD
Nicardipine—Urine output increased—Vincristine—colon cancer	0.00123	0.0111	CcSEcCtD
Nicardipine—Oropharyngeal discomfort—Capecitabine—colon cancer	0.00122	0.011	CcSEcCtD
Nicardipine—CACNA2D1—vagina—colon cancer	0.00121	0.0115	CbGeAlD
Nicardipine—CACNA1C—digestive system—colon cancer	0.00117	0.0112	CbGeAlD
Nicardipine—PDE1A—lymph node—colon cancer	0.00113	0.0107	CbGeAlD
Nicardipine—Polyuria—Vincristine—colon cancer	0.00112	0.0101	CcSEcCtD
Nicardipine—Injection site pain—Capecitabine—colon cancer	0.00109	0.00977	CcSEcCtD
Nicardipine—Deep vein thrombosis—Methotrexate—colon cancer	0.00108	0.00976	CcSEcCtD
Nicardipine—CACNB2—liver—colon cancer	0.00108	0.0103	CbGeAlD
Nicardipine—Extrasystoles—Capecitabine—colon cancer	0.00105	0.00948	CcSEcCtD
Nicardipine—CACNA1C—vagina—colon cancer	0.00104	0.00989	CbGeAlD
Nicardipine—CACNA2D1—liver—colon cancer	0.00102	0.00971	CbGeAlD
Nicardipine—CALM2—epithelium—colon cancer	0.00101	0.00968	CbGeAlD
Nicardipine—CALM1—epithelium—colon cancer	0.00101	0.00963	CbGeAlD
Nicardipine—CHRM3—smooth muscle tissue—colon cancer	0.000999	0.00953	CbGeAlD
Nicardipine—Ventricular extrasystoles—Capecitabine—colon cancer	0.000981	0.00883	CcSEcCtD
Nicardipine—CALM2—smooth muscle tissue—colon cancer	0.000978	0.00933	CbGeAlD
Nicardipine—Oropharyngeal pain—Capecitabine—colon cancer	0.000975	0.00877	CcSEcCtD
Nicardipine—CALM1—smooth muscle tissue—colon cancer	0.000973	0.00928	CbGeAlD
Nicardipine—CHRM3—renal system—colon cancer	0.000962	0.00917	CbGeAlD
Nicardipine—Nocturia—Capecitabine—colon cancer	0.000956	0.0086	CcSEcCtD
Nicardipine—ADRA1A—epithelium—colon cancer	0.000952	0.00908	CbGeAlD
Nicardipine—CACNA1D—liver—colon cancer	0.000947	0.00903	CbGeAlD
Nicardipine—CALM2—renal system—colon cancer	0.000941	0.00898	CbGeAlD
Nicardipine—CALM1—renal system—colon cancer	0.000937	0.00894	CbGeAlD
Nicardipine—CALM3—bone marrow—colon cancer	0.000906	0.00864	CbGeAlD
Nicardipine—Neck pain—Capecitabine—colon cancer	0.000897	0.00808	CcSEcCtD
Nicardipine—ADRA1A—renal system—colon cancer	0.000883	0.00842	CbGeAlD
Nicardipine—Injection site reaction—Capecitabine—colon cancer	0.000881	0.00793	CcSEcCtD
Nicardipine—Orthostatic hypotension—Irinotecan—colon cancer	0.000878	0.0079	CcSEcCtD
Nicardipine—Hypokalaemia—Irinotecan—colon cancer	0.000875	0.00788	CcSEcCtD
Nicardipine—CALM3—vagina—colon cancer	0.000868	0.00828	CbGeAlD
Nicardipine—CACNB2—lymph node—colon cancer	0.000831	0.00792	CbGeAlD
Nicardipine—ABCB1—blood vessel—colon cancer	0.000828	0.0079	CbGeAlD
Nicardipine—Angina pectoris—Irinotecan—colon cancer	0.000809	0.00729	CcSEcCtD
Nicardipine—Sweating increased—Irinotecan—colon cancer	0.000809	0.00729	CcSEcCtD
Nicardipine—Urine output increased—Capecitabine—colon cancer	0.000801	0.00721	CcSEcCtD
Nicardipine—CHRM3—digestive system—colon cancer	0.000789	0.00752	CbGeAlD
Nicardipine—Erectile dysfunction—Vincristine—colon cancer	0.000786	0.00707	CcSEcCtD
Nicardipine—CALM2—lymphoid tissue—colon cancer	0.000782	0.00745	CbGeAlD
Nicardipine—CACNA2D1—lymph node—colon cancer	0.00078	0.00744	CbGeAlD
Nicardipine—CYP2C8—renal system—colon cancer	0.00078	0.00744	CbGeAlD
Nicardipine—CALM1—lymphoid tissue—colon cancer	0.000778	0.00742	CbGeAlD
Nicardipine—Angina pectoris—Fluorouracil—colon cancer	0.000775	0.00698	CcSEcCtD
Nicardipine—Abnormal vision—Capecitabine—colon cancer	0.000773	0.00696	CcSEcCtD
Nicardipine—CALM2—digestive system—colon cancer	0.000772	0.00736	CbGeAlD
Nicardipine—CALM1—digestive system—colon cancer	0.000768	0.00733	CbGeAlD
Nicardipine—Acute coronary syndrome—Vincristine—colon cancer	0.00075	0.00675	CcSEcCtD
Nicardipine—Myocardial infarction—Vincristine—colon cancer	0.000746	0.00671	CcSEcCtD
Nicardipine—CYP2C19—digestive system—colon cancer	0.000733	0.00699	CbGeAlD
Nicardipine—ADRA1A—lymphoid tissue—colon cancer	0.000733	0.00699	CbGeAlD
Nicardipine—Polyuria—Capecitabine—colon cancer	0.000733	0.0066	CcSEcCtD
Nicardipine—CALM3—liver—colon cancer	0.000732	0.00699	CbGeAlD
Nicardipine—Acute coronary syndrome—Irinotecan—colon cancer	0.00073	0.00657	CcSEcCtD
Nicardipine—Sweating—Vincristine—colon cancer	0.000729	0.00656	CcSEcCtD
Nicardipine—CACNA1D—lymph node—colon cancer	0.000726	0.00693	CbGeAlD
Nicardipine—Myocardial infarction—Irinotecan—colon cancer	0.000726	0.00654	CcSEcCtD
Nicardipine—CALM2—bone marrow—colon cancer	0.000712	0.00679	CbGeAlD
Nicardipine—Sweating—Irinotecan—colon cancer	0.00071	0.00639	CcSEcCtD
Nicardipine—CALM1—bone marrow—colon cancer	0.000708	0.00676	CbGeAlD
Nicardipine—CYP3A5—renal system—colon cancer	0.000704	0.00672	CbGeAlD
Nicardipine—CYP2B6—renal system—colon cancer	0.0007	0.00667	CbGeAlD
Nicardipine—Acute coronary syndrome—Fluorouracil—colon cancer	0.000699	0.0063	CcSEcCtD
Nicardipine—Myocardial infarction—Fluorouracil—colon cancer	0.000696	0.00626	CcSEcCtD
Nicardipine—Conjunctivitis—Fluorouracil—colon cancer	0.00069	0.00621	CcSEcCtD
Nicardipine—Hot flush—Capecitabine—colon cancer	0.000688	0.00619	CcSEcCtD
Nicardipine—Menopausal symptoms—Capecitabine—colon cancer	0.000682	0.00614	CcSEcCtD
Nicardipine—CALM2—vagina—colon cancer	0.000682	0.0065	CbGeAlD
Nicardipine—Hypoaesthesia—Vincristine—colon cancer	0.000679	0.00612	CcSEcCtD
Nicardipine—Atrial fibrillation—Capecitabine—colon cancer	0.000679	0.00611	CcSEcCtD
Nicardipine—CALM1—vagina—colon cancer	0.000679	0.00647	CbGeAlD
Nicardipine—CACNA1C—lymph node—colon cancer	0.00067	0.00639	CbGeAlD
Nicardipine—Rhinitis—Irinotecan—colon cancer	0.000667	0.006	CcSEcCtD
Nicardipine—Sinusitis—Fluorouracil—colon cancer	0.000666	0.00599	CcSEcCtD
Nicardipine—CYP2E1—renal system—colon cancer	0.000657	0.00626	CbGeAlD
Nicardipine—CYP2C19—vagina—colon cancer	0.000647	0.00617	CbGeAlD
Nicardipine—Visual impairment—Irinotecan—colon cancer	0.000641	0.00577	CcSEcCtD
Nicardipine—Rhinitis—Fluorouracil—colon cancer	0.000639	0.00575	CcSEcCtD
Nicardipine—Hypoaesthesia—Fluorouracil—colon cancer	0.000634	0.00571	CcSEcCtD
Nicardipine—Face oedema—Capecitabine—colon cancer	0.000621	0.00559	CcSEcCtD
Nicardipine—Flushing—Irinotecan—colon cancer	0.000617	0.00556	CcSEcCtD
Nicardipine—Urine output increased—Methotrexate—colon cancer	0.000597	0.00537	CcSEcCtD
Nicardipine—Orthostatic hypotension—Capecitabine—colon cancer	0.000588	0.00529	CcSEcCtD
Nicardipine—Hypokalaemia—Capecitabine—colon cancer	0.000586	0.00527	CcSEcCtD
Nicardipine—CYP2B6—lymphoid tissue—colon cancer	0.000581	0.00554	CbGeAlD
Nicardipine—CYP3A5—digestive system—colon cancer	0.000577	0.00551	CbGeAlD
Nicardipine—CALM2—liver—colon cancer	0.000575	0.00549	CbGeAlD
Nicardipine—CYP2B6—digestive system—colon cancer	0.000574	0.00547	CbGeAlD
Nicardipine—CALM1—liver—colon cancer	0.000572	0.00546	CbGeAlD
Nicardipine—CYP2C9—digestive system—colon cancer	0.000568	0.00542	CbGeAlD
Nicardipine—CYP2C8—vagina—colon cancer	0.000565	0.00539	CbGeAlD
Nicardipine—CALM3—lymph node—colon cancer	0.000562	0.00536	CbGeAlD
Nicardipine—Agitation—Vincristine—colon cancer	0.000546	0.00492	CcSEcCtD
Nicardipine—CYP2C19—liver—colon cancer	0.000546	0.00521	CbGeAlD
Nicardipine—Polyuria—Methotrexate—colon cancer	0.000545	0.00491	CcSEcCtD
Nicardipine—CYP2E1—lymphoid tissue—colon cancer	0.000545	0.0052	CbGeAlD
Nicardipine—Angina pectoris—Capecitabine—colon cancer	0.000542	0.00488	CcSEcCtD
Nicardipine—Sweating increased—Capecitabine—colon cancer	0.000542	0.00488	CcSEcCtD
Nicardipine—ADRA1A—liver—colon cancer	0.000539	0.00515	CbGeAlD
Nicardipine—CYP2E1—digestive system—colon cancer	0.000539	0.00514	CbGeAlD
Nicardipine—Ill-defined disorder—Irinotecan—colon cancer	0.000537	0.00484	CcSEcCtD
Nicardipine—Vertigo—Vincristine—colon cancer	0.000534	0.00481	CcSEcCtD
Nicardipine—CYP3A4—renal system—colon cancer	0.000528	0.00504	CbGeAlD
Nicardipine—Vision blurred—Fluorouracil—colon cancer	0.000523	0.0047	CcSEcCtD
Nicardipine—Malaise—Irinotecan—colon cancer	0.000522	0.0047	CcSEcCtD
Nicardipine—Vertigo—Irinotecan—colon cancer	0.00052	0.00468	CcSEcCtD
Nicardipine—CYP2D6—renal system—colon cancer	0.00052	0.00496	CbGeAlD
Nicardipine—Syncope—Irinotecan—colon cancer	0.000519	0.00467	CcSEcCtD
Nicardipine—Nisoldipine—ABCB1—colon cancer	0.000516	0.238	CrCbGaD
Nicardipine—Hypertension—Vincristine—colon cancer	0.000513	0.00462	CcSEcCtD
Nicardipine—CYP3A5—vagina—colon cancer	0.00051	0.00486	CbGeAlD
Nicardipine—Loss of consciousness—Irinotecan—colon cancer	0.000509	0.00458	CcSEcCtD
Nicardipine—CYP2B6—vagina—colon cancer	0.000507	0.00483	CbGeAlD
Nicardipine—Myalgia—Vincristine—colon cancer	0.000506	0.00456	CcSEcCtD
Nicardipine—Hypertension—Irinotecan—colon cancer	0.0005	0.0045	CcSEcCtD
Nicardipine—ABCB1—embryo—colon cancer	0.000494	0.00471	CbGeAlD
Nicardipine—Acute coronary syndrome—Capecitabine—colon cancer	0.000489	0.0044	CcSEcCtD
Nicardipine—Discomfort—Irinotecan—colon cancer	0.000487	0.00438	CcSEcCtD
Nicardipine—Myocardial infarction—Capecitabine—colon cancer	0.000486	0.00438	CcSEcCtD
Nicardipine—Oedema—Vincristine—colon cancer	0.000485	0.00437	CcSEcCtD
Nicardipine—Nitrendipine—ABCB1—colon cancer	0.000482	0.222	CrCbGaD
Nicardipine—Infection—Vincristine—colon cancer	0.000482	0.00434	CcSEcCtD
Nicardipine—Conjunctivitis—Capecitabine—colon cancer	0.000482	0.00434	CcSEcCtD
Nicardipine—CYP2C8—liver—colon cancer	0.000477	0.00455	CbGeAlD
Nicardipine—Confusional state—Irinotecan—colon cancer	0.000476	0.00429	CcSEcCtD
Nicardipine—Thrombocytopenia—Vincristine—colon cancer	0.000475	0.00428	CcSEcCtD
Nicardipine—Haematuria—Capecitabine—colon cancer	0.000473	0.00426	CcSEcCtD
Nicardipine—Oedema—Irinotecan—colon cancer	0.000472	0.00425	CcSEcCtD
Nicardipine—Myalgia—Fluorouracil—colon cancer	0.000472	0.00425	CcSEcCtD
Nicardipine—Chest pain—Fluorouracil—colon cancer	0.000472	0.00425	CcSEcCtD
Nicardipine—Infection—Irinotecan—colon cancer	0.000469	0.00423	CcSEcCtD
Nicardipine—Hyperhidrosis—Vincristine—colon cancer	0.000469	0.00422	CcSEcCtD
Nicardipine—Discomfort—Fluorouracil—colon cancer	0.000466	0.0042	CcSEcCtD
Nicardipine—Shock—Irinotecan—colon cancer	0.000465	0.00418	CcSEcCtD
Nicardipine—Thrombocytopenia—Irinotecan—colon cancer	0.000463	0.00416	CcSEcCtD
Nicardipine—Hyperhidrosis—Irinotecan—colon cancer	0.000457	0.00411	CcSEcCtD
Nicardipine—Confusional state—Fluorouracil—colon cancer	0.000456	0.00411	CcSEcCtD
Nicardipine—Hypotension—Vincristine—colon cancer	0.000453	0.00408	CcSEcCtD
Nicardipine—Oedema—Fluorouracil—colon cancer	0.000453	0.00407	CcSEcCtD
Nicardipine—Infection—Fluorouracil—colon cancer	0.00045	0.00405	CcSEcCtD
Nicardipine—Rhinitis—Capecitabine—colon cancer	0.000446	0.00402	CcSEcCtD
Nicardipine—Thrombocytopenia—Fluorouracil—colon cancer	0.000443	0.00399	CcSEcCtD
Nicardipine—Hypoaesthesia—Capecitabine—colon cancer	0.000443	0.00399	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000442	0.00398	CcSEcCtD
Nicardipine—Tachycardia—Fluorouracil—colon cancer	0.000442	0.00398	CcSEcCtD
Nicardipine—Hypotension—Irinotecan—colon cancer	0.000442	0.00397	CcSEcCtD
Nicardipine—CALM2—lymph node—colon cancer	0.000441	0.00421	CbGeAlD
Nicardipine—CALM1—lymph node—colon cancer	0.000439	0.00419	CbGeAlD
Nicardipine—Insomnia—Vincristine—colon cancer	0.000439	0.00395	CcSEcCtD
Nicardipine—Oedema peripheral—Capecitabine—colon cancer	0.000438	0.00395	CcSEcCtD
Nicardipine—Paraesthesia—Vincristine—colon cancer	0.000436	0.00392	CcSEcCtD
Nicardipine—CYP3A4—digestive system—colon cancer	0.000433	0.00413	CbGeAlD
Nicardipine—CYP3A5—liver—colon cancer	0.00043	0.0041	CbGeAlD
Nicardipine—Visual impairment—Capecitabine—colon cancer	0.000429	0.00386	CcSEcCtD
Nicardipine—CYP2B6—liver—colon cancer	0.000428	0.00408	CbGeAlD
Nicardipine—Insomnia—Irinotecan—colon cancer	0.000427	0.00385	CcSEcCtD
Nicardipine—CYP2D6—digestive system—colon cancer	0.000426	0.00407	CbGeAlD
Nicardipine—Paraesthesia—Irinotecan—colon cancer	0.000424	0.00382	CcSEcCtD
Nicardipine—CYP2C9—liver—colon cancer	0.000423	0.00404	CbGeAlD
Nicardipine—Hypotension—Fluorouracil—colon cancer	0.000423	0.00381	CcSEcCtD
Nicardipine—Dyspnoea—Irinotecan—colon cancer	0.000421	0.00379	CcSEcCtD
Nicardipine—Somnolence—Irinotecan—colon cancer	0.00042	0.00378	CcSEcCtD
Nicardipine—Dyspepsia—Irinotecan—colon cancer	0.000416	0.00374	CcSEcCtD
Nicardipine—Amlodipine—ABCB1—colon cancer	0.000415	0.191	CrCbGaD
Nicardipine—Tinnitus—Capecitabine—colon cancer	0.000415	0.00374	CcSEcCtD
Nicardipine—Pain—Vincristine—colon cancer	0.000415	0.00373	CcSEcCtD
Nicardipine—Constipation—Vincristine—colon cancer	0.000415	0.00373	CcSEcCtD
Nicardipine—Flushing—Capecitabine—colon cancer	0.000413	0.00372	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000412	0.00371	CcSEcCtD
Nicardipine—Insomnia—Fluorouracil—colon cancer	0.000409	0.00368	CcSEcCtD
Nicardipine—Paraesthesia—Fluorouracil—colon cancer	0.000406	0.00366	CcSEcCtD
Nicardipine—Pain—Irinotecan—colon cancer	0.000404	0.00364	CcSEcCtD
Nicardipine—Constipation—Irinotecan—colon cancer	0.000404	0.00364	CcSEcCtD
Nicardipine—Dyspnoea—Fluorouracil—colon cancer	0.000403	0.00363	CcSEcCtD
Nicardipine—ABCB1—epithelium—colon cancer	0.000403	0.00385	CbGeAlD
Nicardipine—Somnolence—Fluorouracil—colon cancer	0.000402	0.00362	CcSEcCtD
Nicardipine—CYP2E1—liver—colon cancer	0.000401	0.00383	CbGeAlD
Nicardipine—Dyspepsia—Fluorouracil—colon cancer	0.000398	0.00359	CcSEcCtD
Nicardipine—Gastrointestinal pain—Vincristine—colon cancer	0.000397	0.00357	CcSEcCtD
Nicardipine—Feeling abnormal—Irinotecan—colon cancer	0.000389	0.0035	CcSEcCtD
Nicardipine—Pain—Fluorouracil—colon cancer	0.000387	0.00348	CcSEcCtD
Nicardipine—Gastrointestinal pain—Irinotecan—colon cancer	0.000386	0.00348	CcSEcCtD
Nicardipine—Felodipine—ABCB1—colon cancer	0.000384	0.177	CrCbGaD
Nicardipine—Body temperature increased—Vincristine—colon cancer	0.000384	0.00345	CcSEcCtD
Nicardipine—Abdominal pain—Vincristine—colon cancer	0.000384	0.00345	CcSEcCtD
Nicardipine—Erectile dysfunction—Methotrexate—colon cancer	0.000381	0.00343	CcSEcCtD
Nicardipine—ABCB1—renal system—colon cancer	0.000374	0.00357	CbGeAlD
Nicardipine—Abdominal pain—Irinotecan—colon cancer	0.000374	0.00336	CcSEcCtD
Nicardipine—Body temperature increased—Irinotecan—colon cancer	0.000374	0.00336	CcSEcCtD
Nicardipine—Feeling abnormal—Fluorouracil—colon cancer	0.000373	0.00336	CcSEcCtD
Nicardipine—Nifedipine—ABCB1—colon cancer	0.000371	0.171	CrCbGaD
Nicardipine—Vision blurred—Capecitabine—colon cancer	0.000365	0.00329	CcSEcCtD
Nicardipine—Tremor—Capecitabine—colon cancer	0.000363	0.00327	CcSEcCtD
Nicardipine—Ill-defined disorder—Capecitabine—colon cancer	0.00036	0.00324	CcSEcCtD
Nicardipine—Conjunctivitis—Methotrexate—colon cancer	0.000359	0.00323	CcSEcCtD
Nicardipine—Body temperature increased—Fluorouracil—colon cancer	0.000358	0.00322	CcSEcCtD
Nicardipine—Hypersensitivity—Vincristine—colon cancer	0.000357	0.00322	CcSEcCtD
Nicardipine—Sweating—Methotrexate—colon cancer	0.000354	0.00319	CcSEcCtD
Nicardipine—Haematuria—Methotrexate—colon cancer	0.000352	0.00317	CcSEcCtD
Nicardipine—Malaise—Capecitabine—colon cancer	0.000349	0.00315	CcSEcCtD
Nicardipine—Vertigo—Capecitabine—colon cancer	0.000348	0.00313	CcSEcCtD
Nicardipine—Hypersensitivity—Irinotecan—colon cancer	0.000348	0.00313	CcSEcCtD
Nicardipine—Asthenia—Vincristine—colon cancer	0.000348	0.00313	CcSEcCtD
Nicardipine—Syncope—Capecitabine—colon cancer	0.000347	0.00313	CcSEcCtD
Nicardipine—Palpitations—Capecitabine—colon cancer	0.000342	0.00308	CcSEcCtD
Nicardipine—Loss of consciousness—Capecitabine—colon cancer	0.000341	0.00307	CcSEcCtD
Nicardipine—Asthenia—Irinotecan—colon cancer	0.000339	0.00305	CcSEcCtD
Nicardipine—Hypertension—Capecitabine—colon cancer	0.000335	0.00301	CcSEcCtD
Nicardipine—Hypersensitivity—Fluorouracil—colon cancer	0.000333	0.003	CcSEcCtD
Nicardipine—Diarrhoea—Vincristine—colon cancer	0.000332	0.00299	CcSEcCtD
Nicardipine—Arthralgia—Capecitabine—colon cancer	0.00033	0.00297	CcSEcCtD
Nicardipine—Chest pain—Capecitabine—colon cancer	0.00033	0.00297	CcSEcCtD
Nicardipine—Myalgia—Capecitabine—colon cancer	0.00033	0.00297	CcSEcCtD
Nicardipine—Anxiety—Capecitabine—colon cancer	0.000329	0.00296	CcSEcCtD
Nicardipine—Discomfort—Capecitabine—colon cancer	0.000326	0.00293	CcSEcCtD
Nicardipine—Diarrhoea—Irinotecan—colon cancer	0.000323	0.00291	CcSEcCtD
Nicardipine—CYP3A4—liver—colon cancer	0.000323	0.00308	CbGeAlD
Nicardipine—Dry mouth—Capecitabine—colon cancer	0.000323	0.0029	CcSEcCtD
Nicardipine—Dizziness—Vincristine—colon cancer	0.000321	0.00289	CcSEcCtD
Nicardipine—Visual impairment—Methotrexate—colon cancer	0.000319	0.00287	CcSEcCtD
Nicardipine—Confusional state—Capecitabine—colon cancer	0.000319	0.00287	CcSEcCtD
Nicardipine—CYP2D6—liver—colon cancer	0.000318	0.00303	CbGeAlD
Nicardipine—Oedema—Capecitabine—colon cancer	0.000316	0.00285	CcSEcCtD
Nicardipine—Infection—Capecitabine—colon cancer	0.000314	0.00283	CcSEcCtD
Nicardipine—Dizziness—Irinotecan—colon cancer	0.000312	0.00281	CcSEcCtD
Nicardipine—Shock—Capecitabine—colon cancer	0.000311	0.0028	CcSEcCtD
Nicardipine—ABCB1—lymphoid tissue—colon cancer	0.000311	0.00296	CbGeAlD
Nicardipine—Diarrhoea—Fluorouracil—colon cancer	0.00031	0.00279	CcSEcCtD
Nicardipine—Thrombocytopenia—Capecitabine—colon cancer	0.00031	0.00279	CcSEcCtD
Nicardipine—Tinnitus—Methotrexate—colon cancer	0.000309	0.00278	CcSEcCtD
Nicardipine—Tachycardia—Capecitabine—colon cancer	0.000309	0.00278	CcSEcCtD
Nicardipine—Vomiting—Vincristine—colon cancer	0.000308	0.00278	CcSEcCtD
Nicardipine—ABCB1—digestive system—colon cancer	0.000307	0.00293	CbGeAlD
Nicardipine—Rash—Vincristine—colon cancer	0.000306	0.00275	CcSEcCtD
Nicardipine—Hyperhidrosis—Capecitabine—colon cancer	0.000306	0.00275	CcSEcCtD
Nicardipine—Dermatitis—Vincristine—colon cancer	0.000306	0.00275	CcSEcCtD
Nicardipine—Headache—Vincristine—colon cancer	0.000304	0.00274	CcSEcCtD
Nicardipine—Vomiting—Irinotecan—colon cancer	0.0003	0.0027	CcSEcCtD
Nicardipine—Dizziness—Fluorouracil—colon cancer	0.000299	0.00269	CcSEcCtD
Nicardipine—Rash—Irinotecan—colon cancer	0.000298	0.00268	CcSEcCtD
Nicardipine—Dermatitis—Irinotecan—colon cancer	0.000298	0.00268	CcSEcCtD
Nicardipine—Headache—Irinotecan—colon cancer	0.000296	0.00266	CcSEcCtD
Nicardipine—Hypotension—Capecitabine—colon cancer	0.000295	0.00266	CcSEcCtD
Nicardipine—Nausea—Vincristine—colon cancer	0.000288	0.00259	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000288	0.00259	CcSEcCtD
Nicardipine—Vomiting—Fluorouracil—colon cancer	0.000288	0.00259	CcSEcCtD
Nicardipine—Insomnia—Capecitabine—colon cancer	0.000286	0.00257	CcSEcCtD
Nicardipine—Rash—Fluorouracil—colon cancer	0.000285	0.00257	CcSEcCtD
Nicardipine—Dermatitis—Fluorouracil—colon cancer	0.000285	0.00257	CcSEcCtD
Nicardipine—Paraesthesia—Capecitabine—colon cancer	0.000284	0.00256	CcSEcCtD
Nicardipine—Headache—Fluorouracil—colon cancer	0.000283	0.00255	CcSEcCtD
Nicardipine—ABCB1—bone marrow—colon cancer	0.000283	0.0027	CbGeAlD
Nicardipine—Dyspnoea—Capecitabine—colon cancer	0.000282	0.00254	CcSEcCtD
Nicardipine—Nausea—Irinotecan—colon cancer	0.000281	0.00253	CcSEcCtD
Nicardipine—Dyspepsia—Capecitabine—colon cancer	0.000278	0.00251	CcSEcCtD
Nicardipine—Vision blurred—Methotrexate—colon cancer	0.000272	0.00245	CcSEcCtD
Nicardipine—ABCB1—vagina—colon cancer	0.000271	0.00258	CbGeAlD
Nicardipine—Constipation—Capecitabine—colon cancer	0.00027	0.00243	CcSEcCtD
Nicardipine—Pain—Capecitabine—colon cancer	0.00027	0.00243	CcSEcCtD
Nicardipine—Nausea—Fluorouracil—colon cancer	0.000269	0.00242	CcSEcCtD
Nicardipine—Ill-defined disorder—Methotrexate—colon cancer	0.000268	0.00241	CcSEcCtD
Nicardipine—Feeling abnormal—Capecitabine—colon cancer	0.000261	0.00235	CcSEcCtD
Nicardipine—Malaise—Methotrexate—colon cancer	0.00026	0.00234	CcSEcCtD
Nicardipine—Vertigo—Methotrexate—colon cancer	0.000259	0.00233	CcSEcCtD
Nicardipine—Gastrointestinal pain—Capecitabine—colon cancer	0.000259	0.00233	CcSEcCtD
Nicardipine—Abdominal pain—Capecitabine—colon cancer	0.00025	0.00225	CcSEcCtD
Nicardipine—Body temperature increased—Capecitabine—colon cancer	0.00025	0.00225	CcSEcCtD
Nicardipine—Myalgia—Methotrexate—colon cancer	0.000246	0.00221	CcSEcCtD
Nicardipine—Chest pain—Methotrexate—colon cancer	0.000246	0.00221	CcSEcCtD
Nicardipine—Arthralgia—Methotrexate—colon cancer	0.000246	0.00221	CcSEcCtD
Nicardipine—Discomfort—Methotrexate—colon cancer	0.000243	0.00218	CcSEcCtD
Nicardipine—Confusional state—Methotrexate—colon cancer	0.000237	0.00214	CcSEcCtD
Nicardipine—Infection—Methotrexate—colon cancer	0.000234	0.00211	CcSEcCtD
Nicardipine—Hypersensitivity—Capecitabine—colon cancer	0.000233	0.0021	CcSEcCtD
Nicardipine—Thrombocytopenia—Methotrexate—colon cancer	0.00023	0.00207	CcSEcCtD
Nicardipine—ABCB1—liver—colon cancer	0.000229	0.00218	CbGeAlD
Nicardipine—Hyperhidrosis—Methotrexate—colon cancer	0.000228	0.00205	CcSEcCtD
Nicardipine—Asthenia—Capecitabine—colon cancer	0.000227	0.00204	CcSEcCtD
Nicardipine—Hypotension—Methotrexate—colon cancer	0.00022	0.00198	CcSEcCtD
Nicardipine—Diarrhoea—Capecitabine—colon cancer	0.000216	0.00195	CcSEcCtD
Nicardipine—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000214	0.00193	CcSEcCtD
Nicardipine—Insomnia—Methotrexate—colon cancer	0.000213	0.00192	CcSEcCtD
Nicardipine—Paraesthesia—Methotrexate—colon cancer	0.000211	0.0019	CcSEcCtD
Nicardipine—Dyspnoea—Methotrexate—colon cancer	0.00021	0.00189	CcSEcCtD
Nicardipine—Somnolence—Methotrexate—colon cancer	0.000209	0.00188	CcSEcCtD
Nicardipine—Dizziness—Capecitabine—colon cancer	0.000209	0.00188	CcSEcCtD
Nicardipine—Dyspepsia—Methotrexate—colon cancer	0.000207	0.00187	CcSEcCtD
Nicardipine—Pain—Methotrexate—colon cancer	0.000201	0.00181	CcSEcCtD
Nicardipine—Vomiting—Capecitabine—colon cancer	0.000201	0.00181	CcSEcCtD
Nicardipine—Rash—Capecitabine—colon cancer	0.000199	0.00179	CcSEcCtD
Nicardipine—Dermatitis—Capecitabine—colon cancer	0.000199	0.00179	CcSEcCtD
Nicardipine—Headache—Capecitabine—colon cancer	0.000198	0.00178	CcSEcCtD
Nicardipine—Feeling abnormal—Methotrexate—colon cancer	0.000194	0.00175	CcSEcCtD
Nicardipine—Gastrointestinal pain—Methotrexate—colon cancer	0.000193	0.00173	CcSEcCtD
Nicardipine—Nausea—Capecitabine—colon cancer	0.000188	0.00169	CcSEcCtD
Nicardipine—Abdominal pain—Methotrexate—colon cancer	0.000186	0.00168	CcSEcCtD
Nicardipine—Body temperature increased—Methotrexate—colon cancer	0.000186	0.00168	CcSEcCtD
Nicardipine—ABCB1—lymph node—colon cancer	0.000175	0.00167	CbGeAlD
Nicardipine—Hypersensitivity—Methotrexate—colon cancer	0.000173	0.00156	CcSEcCtD
Nicardipine—Asthenia—Methotrexate—colon cancer	0.000169	0.00152	CcSEcCtD
Nicardipine—Diarrhoea—Methotrexate—colon cancer	0.000161	0.00145	CcSEcCtD
Nicardipine—Dizziness—Methotrexate—colon cancer	0.000156	0.0014	CcSEcCtD
Nicardipine—Vomiting—Methotrexate—colon cancer	0.00015	0.00135	CcSEcCtD
Nicardipine—Rash—Methotrexate—colon cancer	0.000148	0.00134	CcSEcCtD
Nicardipine—Dermatitis—Methotrexate—colon cancer	0.000148	0.00133	CcSEcCtD
Nicardipine—Headache—Methotrexate—colon cancer	0.000147	0.00133	CcSEcCtD
Nicardipine—Nausea—Methotrexate—colon cancer	0.00014	0.00126	CcSEcCtD
Nicardipine—ADRA1A—Signaling by GPCR—HRAS—colon cancer	8.29e-06	6.17e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—EGFR—colon cancer	8.27e-06	6.16e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—KRAS—colon cancer	8.26e-06	6.15e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling by GPCR—AKT1—colon cancer	8.24e-06	6.13e-05	CbGpPWpGaD
Nicardipine—CHRM1—GPCR downstream signaling—AKT1—colon cancer	8.18e-06	6.09e-05	CbGpPWpGaD
Nicardipine—CHRM3—GPCR downstream signaling—AKT1—colon cancer	8.16e-06	6.07e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—SRC—colon cancer	8.15e-06	6.06e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—SRC—colon cancer	8.15e-06	6.06e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CASP3—colon cancer	8.11e-06	6.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—NRAS—colon cancer	8.1e-06	6.03e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CASP3—colon cancer	8.08e-06	6.02e-05	CbGpPWpGaD
Nicardipine—CHRM2—GPCR downstream signaling—AKT1—colon cancer	8.08e-06	6.02e-05	CbGpPWpGaD
Nicardipine—ADRA1A—GPCR downstream signaling—AKT1—colon cancer	8.06e-06	6e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EP300—colon cancer	8.05e-06	5.99e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CASP3—colon cancer	8e-06	5.96e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—KRAS—colon cancer	7.99e-06	5.95e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—KRAS—colon cancer	7.99e-06	5.95e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—EGFR—colon cancer	7.99e-06	5.95e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CASP3—colon cancer	7.98e-06	5.94e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—PIK3CA—colon cancer	7.97e-06	5.93e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PPARG—colon cancer	7.92e-06	5.89e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CCND1—colon cancer	7.89e-06	5.88e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CCND1—colon cancer	7.87e-06	5.86e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PPARG—colon cancer	7.85e-06	5.84e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—NRAS—colon cancer	7.84e-06	5.83e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—NRAS—colon cancer	7.84e-06	5.83e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—SRC—colon cancer	7.83e-06	5.83e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CTNNB1—colon cancer	7.82e-06	5.82e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—KRAS—colon cancer	7.81e-06	5.82e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CCND1—colon cancer	7.79e-06	5.8e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CTNNB1—colon cancer	7.79e-06	5.8e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CCND1—colon cancer	7.77e-06	5.78e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—EGFR—colon cancer	7.73e-06	5.76e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—EGFR—colon cancer	7.73e-06	5.76e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CTNNB1—colon cancer	7.72e-06	5.74e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—TP53—colon cancer	7.71e-06	5.74e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CTNNB1—colon cancer	7.69e-06	5.73e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—CDKN1A—colon cancer	7.64e-06	5.68e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—PIK3CA—colon cancer	7.63e-06	5.68e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—VEGFA—colon cancer	7.63e-06	5.68e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—CDKN1A—colon cancer	7.61e-06	5.67e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—PIK3CA—colon cancer	7.59e-06	5.65e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PTGS2—colon cancer	7.58e-06	5.65e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—KRAS—colon cancer	7.55e-06	5.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—MYC—colon cancer	7.55e-06	5.62e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—CDKN1A—colon cancer	7.54e-06	5.61e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—NRAS—colon cancer	7.53e-06	5.61e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—TGFB1—colon cancer	7.53e-06	5.6e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—CDKN1A—colon cancer	7.52e-06	5.6e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—EP300—colon cancer	7.45e-06	5.55e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—ABCB1—colon cancer	7.44e-06	5.54e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling by GPCR—AKT1—colon cancer	7.43e-06	5.53e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling by GPCR—AKT1—colon cancer	7.41e-06	5.52e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—TP53—colon cancer	7.38e-06	5.5e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—EGFR—colon cancer	7.38e-06	5.49e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—HRAS—colon cancer	7.37e-06	5.49e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—PIK3CA—colon cancer	7.35e-06	5.47e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—PIK3CA—colon cancer	7.35e-06	5.47e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling by GPCR—AKT1—colon cancer	7.34e-06	5.46e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling by GPCR—AKT1—colon cancer	7.32e-06	5.45e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—TYMS—colon cancer	7.31e-06	5.44e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—KRAS—colon cancer	7.3e-06	5.44e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—KRAS—colon cancer	7.3e-06	5.44e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—MYC—colon cancer	7.3e-06	5.43e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—MYC—colon cancer	7.3e-06	5.43e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—EP300—colon cancer	7.3e-06	5.43e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—EP300—colon cancer	7.28e-06	5.42e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—TGFB1—colon cancer	7.28e-06	5.42e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—TGFB1—colon cancer	7.28e-06	5.42e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EP300—colon cancer	7.27e-06	5.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—EP300—colon cancer	7.25e-06	5.4e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EP300—colon cancer	7.24e-06	5.39e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—PIK3CA—colon cancer	7.18e-06	5.34e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EP300—colon cancer	7.17e-06	5.34e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EP300—colon cancer	7.15e-06	5.32e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—EGFR—colon cancer	7.14e-06	5.32e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—EGFR—colon cancer	7.14e-06	5.32e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—SRC—colon cancer	7.07e-06	5.26e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—HRAS—colon cancer	7.06e-06	5.26e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—SRC—colon cancer	7.04e-06	5.24e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—HRAS—colon cancer	7.03e-06	5.23e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—MYC—colon cancer	7.02e-06	5.22e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—EP300—colon cancer	7.01e-06	5.22e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—EP300—colon cancer	7.01e-06	5.22e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TGFB1—colon cancer	7e-06	5.21e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—SRC—colon cancer	6.97e-06	5.19e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—KRAS—colon cancer	6.97e-06	5.19e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—SRC—colon cancer	6.96e-06	5.18e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—TP53—colon cancer	6.94e-06	5.17e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—PIK3CA—colon cancer	6.94e-06	5.17e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—VEGFA—colon cancer	6.88e-06	5.12e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—EGFR—colon cancer	6.86e-06	5.11e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—VEGFA—colon cancer	6.86e-06	5.11e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—NRAS—colon cancer	6.8e-06	5.06e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—HRAS—colon cancer	6.8e-06	5.06e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—HRAS—colon cancer	6.8e-06	5.06e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—VEGFA—colon cancer	6.79e-06	5.06e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—NRAS—colon cancer	6.78e-06	5.04e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—VEGFA—colon cancer	6.77e-06	5.04e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PTGS2—colon cancer	6.77e-06	5.04e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CASP3—colon cancer	6.77e-06	5.04e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—KRAS—colon cancer	6.74e-06	5.02e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—KRAS—colon cancer	6.74e-06	5.02e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—PIK3CA—colon cancer	6.71e-06	5e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—PIK3CA—colon cancer	6.71e-06	5e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—NRAS—colon cancer	6.71e-06	5e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—NRAS—colon cancer	6.69e-06	4.98e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—HRAS—colon cancer	6.64e-06	4.94e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PTGS2—colon cancer	6.61e-06	4.92e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CCND1—colon cancer	6.59e-06	4.9e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CASP3—colon cancer	6.55e-06	4.87e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CASP3—colon cancer	6.55e-06	4.87e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CTNNB1—colon cancer	6.52e-06	4.86e-05	CbGpPWpGaD
Nicardipine—CHRM4—Signaling Pathways—AKT1—colon cancer	6.51e-06	4.85e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—KRAS—colon cancer	6.48e-06	4.83e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—HRAS—colon cancer	6.42e-06	4.78e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—PIK3CA—colon cancer	6.41e-06	4.77e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—PIK3CA—colon cancer	6.41e-06	4.77e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—CDKN1A—colon cancer	6.37e-06	4.74e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CCND1—colon cancer	6.37e-06	4.74e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CCND1—colon cancer	6.37e-06	4.74e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—MYC—colon cancer	6.33e-06	4.71e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TGFB1—colon cancer	6.32e-06	4.7e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—MYC—colon cancer	6.31e-06	4.7e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CTNNB1—colon cancer	6.31e-06	4.7e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CTNNB1—colon cancer	6.31e-06	4.7e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—EP300—colon cancer	6.31e-06	4.7e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TGFB1—colon cancer	6.3e-06	4.69e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—MYC—colon cancer	6.25e-06	4.65e-05	CbGpPWpGaD
Nicardipine—CHRM5—Signaling Pathways—AKT1—colon cancer	6.24e-06	4.64e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TGFB1—colon cancer	6.23e-06	4.64e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—MYC—colon cancer	6.23e-06	4.64e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PTGS2—colon cancer	6.23e-06	4.64e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TGFB1—colon cancer	6.22e-06	4.63e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—HRAS—colon cancer	6.21e-06	4.62e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—HRAS—colon cancer	6.21e-06	4.62e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling by GPCR—AKT1—colon cancer	6.2e-06	4.62e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—PIK3CA—colon cancer	6.2e-06	4.61e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—PIK3CA—colon cancer	6.2e-06	4.61e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—EGFR—colon cancer	6.19e-06	4.61e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PTGS2—colon cancer	6.17e-06	4.6e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—EGFR—colon cancer	6.17e-06	4.6e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—CDKN1A—colon cancer	6.16e-06	4.59e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—CDKN1A—colon cancer	6.16e-06	4.59e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—EGFR—colon cancer	6.11e-06	4.55e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—EGFR—colon cancer	6.1e-06	4.54e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EP300—colon cancer	6.06e-06	4.51e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling by GPCR—AKT1—colon cancer	6e-06	4.47e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling by GPCR—AKT1—colon cancer	6e-06	4.47e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—PIK3CA—colon cancer	5.96e-06	4.43e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—HRAS—colon cancer	5.93e-06	4.41e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—SRC—colon cancer	5.9e-06	4.39e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EP300—colon cancer	5.87e-06	4.37e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EP300—colon cancer	5.87e-06	4.37e-05	CbGpPWpGaD
Nicardipine—ADRA1D—Signaling Pathways—AKT1—colon cancer	5.86e-06	4.36e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—KRAS—colon cancer	5.85e-06	4.36e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—KRAS—colon cancer	5.83e-06	4.34e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—KRAS—colon cancer	5.77e-06	4.3e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—TP53—colon cancer	5.76e-06	4.29e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—KRAS—colon cancer	5.76e-06	4.29e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—VEGFA—colon cancer	5.74e-06	4.28e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—HRAS—colon cancer	5.73e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—HRAS—colon cancer	5.73e-06	4.27e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—SRC—colon cancer	5.7e-06	4.25e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—SRC—colon cancer	5.7e-06	4.25e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—NRAS—colon cancer	5.67e-06	4.22e-05	CbGpPWpGaD
Nicardipine—CALM3—Immune System—AKT1—colon cancer	5.67e-06	4.22e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—EP300—colon cancer	5.63e-06	4.19e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—VEGFA—colon cancer	5.56e-06	4.14e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—VEGFA—colon cancer	5.56e-06	4.14e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—PIK3CA—colon cancer	5.51e-06	4.1e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—HRAS—colon cancer	5.51e-06	4.1e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—EP300—colon cancer	5.5e-06	4.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—NRAS—colon cancer	5.49e-06	4.09e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—NRAS—colon cancer	5.49e-06	4.09e-05	CbGpPWpGaD
Nicardipine—CALM2—Immune System—AKT1—colon cancer	5.48e-06	4.08e-05	CbGpPWpGaD
Nicardipine—CALM1—Immune System—AKT1—colon cancer	5.48e-06	4.08e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—PIK3CA—colon cancer	5.4e-06	4.02e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—PIK3CA—colon cancer	5.39e-06	4.01e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—PIK3CA—colon cancer	5.37e-06	4e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—PIK3CA—colon cancer	5.36e-06	3.99e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—PIK3CA—colon cancer	5.36e-06	3.99e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—PIK3CA—colon cancer	5.31e-06	3.95e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—PIK3CA—colon cancer	5.29e-06	3.94e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—MYC—colon cancer	5.28e-06	3.93e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TGFB1—colon cancer	5.27e-06	3.92e-05	CbGpPWpGaD
Nicardipine—CHRM3—Metabolism—AKT1—colon cancer	5.23e-06	3.9e-05	CbGpPWpGaD
Nicardipine—CALM3—Disease—AKT1—colon cancer	5.23e-06	3.9e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—TP53—colon cancer	5.2e-06	3.87e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—PIK3CA—colon cancer	5.19e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—PIK3CA—colon cancer	5.19e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—TP53—colon cancer	5.18e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—EP300—colon cancer	5.18e-06	3.86e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PPARG—colon cancer	5.18e-06	3.85e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—EGFR—colon cancer	5.17e-06	3.85e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—EP300—colon cancer	5.13e-06	3.82e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—TP53—colon cancer	5.13e-06	3.82e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—TP53—colon cancer	5.12e-06	3.81e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—MYC—colon cancer	5.11e-06	3.81e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—MYC—colon cancer	5.11e-06	3.81e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TGFB1—colon cancer	5.1e-06	3.8e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TGFB1—colon cancer	5.1e-06	3.8e-05	CbGpPWpGaD
Nicardipine—CALM1—Disease—AKT1—colon cancer	5.06e-06	3.77e-05	CbGpPWpGaD
Nicardipine—CALM2—Disease—AKT1—colon cancer	5.06e-06	3.77e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—EGFR—colon cancer	5e-06	3.72e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—EGFR—colon cancer	5e-06	3.72e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—HRAS—colon cancer	4.97e-06	3.7e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—HRAS—colon cancer	4.96e-06	3.69e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—HRAS—colon cancer	4.91e-06	3.65e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—HRAS—colon cancer	4.9e-06	3.64e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—KRAS—colon cancer	4.88e-06	3.63e-05	CbGpPWpGaD
Nicardipine—ADRA1B—Signaling Pathways—AKT1—colon cancer	4.87e-06	3.62e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—KRAS—colon cancer	4.72e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—KRAS—colon cancer	4.72e-06	3.52e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—PIK3CA—colon cancer	4.67e-06	3.47e-05	CbGpPWpGaD
Nicardipine—CYP2B6—Metabolism—AKT1—colon cancer	4.5e-06	3.35e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—PIK3CA—colon cancer	4.49e-06	3.34e-05	CbGpPWpGaD
Nicardipine—CYP2E1—Metabolism—AKT1—colon cancer	4.41e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CYP3A5—Metabolism—AKT1—colon cancer	4.4e-06	3.28e-05	CbGpPWpGaD
Nicardipine—CHRM1—Signaling Pathways—AKT1—colon cancer	4.39e-06	3.27e-05	CbGpPWpGaD
Nicardipine—CALM3—Metabolism—AKT1—colon cancer	4.38e-06	3.26e-05	CbGpPWpGaD
Nicardipine—CHRM3—Signaling Pathways—AKT1—colon cancer	4.38e-06	3.26e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—TP53—colon cancer	4.34e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—PIK3CA—colon cancer	4.34e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—PIK3CA—colon cancer	4.34e-06	3.23e-05	CbGpPWpGaD
Nicardipine—CHRM2—Signaling Pathways—AKT1—colon cancer	4.33e-06	3.23e-05	CbGpPWpGaD
Nicardipine—ADRA1A—Signaling Pathways—AKT1—colon cancer	4.32e-06	3.22e-05	CbGpPWpGaD
Nicardipine—CALM2—Metabolism—AKT1—colon cancer	4.24e-06	3.16e-05	CbGpPWpGaD
Nicardipine—CALM1—Metabolism—AKT1—colon cancer	4.24e-06	3.16e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—TP53—colon cancer	4.2e-06	3.13e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—TP53—colon cancer	4.2e-06	3.13e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—PIK3CA—colon cancer	4.17e-06	3.1e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—HRAS—colon cancer	4.15e-06	3.09e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PTGS2—colon cancer	4.07e-06	3.03e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—PIK3CA—colon cancer	4.07e-06	3.03e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—HRAS—colon cancer	4.01e-06	2.99e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—HRAS—colon cancer	4.01e-06	2.99e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—PIK3CA—colon cancer	3.83e-06	2.85e-05	CbGpPWpGaD
Nicardipine—CYP2C8—Metabolism—AKT1—colon cancer	3.81e-06	2.84e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—PIK3CA—colon cancer	3.8e-06	2.83e-05	CbGpPWpGaD
Nicardipine—CALM3—Signaling Pathways—AKT1—colon cancer	3.66e-06	2.73e-05	CbGpPWpGaD
Nicardipine—CALM1—Signaling Pathways—AKT1—colon cancer	3.54e-06	2.64e-05	CbGpPWpGaD
Nicardipine—CALM2—Signaling Pathways—AKT1—colon cancer	3.54e-06	2.64e-05	CbGpPWpGaD
Nicardipine—CYP2C19—Metabolism—AKT1—colon cancer	3.4e-06	2.53e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—EP300—colon cancer	3.39e-06	2.52e-05	CbGpPWpGaD
Nicardipine—ABCB1—Metabolism—AKT1—colon cancer	3.32e-06	2.47e-05	CbGpPWpGaD
Nicardipine—CYP2D6—Metabolism—AKT1—colon cancer	3.13e-06	2.33e-05	CbGpPWpGaD
Nicardipine—CYP2C9—Metabolism—AKT1—colon cancer	3.1e-06	2.31e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—PIK3CA—colon cancer	2.5e-06	1.86e-05	CbGpPWpGaD
Nicardipine—CYP3A4—Metabolism—AKT1—colon cancer	2.05e-06	1.52e-05	CbGpPWpGaD
